Agilent and Premier Biosoft are working together to advance lipidomics research.
Agilent Technologies and Premier Biosoft today announced that they will each support the combined use of their respective technologies to help clinical researchers advance lipidomics research.
By integrating complementary technologies, they hope researchers can seamlessly generate and process data, then map complex lipidomic networks to learn more about lipid metabolism associated with disease.
They plan to do this by combining Agilent’s time-of-flight and quadrupole time-of-flight mass spectrometers and Pathway Architect software with Premier Biosoft’s SimLipid 3.3 identification and quantification software.
“Just as challenging as mapping and sequencing the human genome is identifying and sequencing the thousands of lipid species involved in human metabolism,” said Dr Daniel Kassel, Agilent’s senior director of LC/MS global marketing.
“By connecting these complementary technologies, researchers can maximise the analytical capabilities of Agilent’s high-end MS instrumentation and software with our high-throughput MS and MS/MS data analysis tools,” said Arun Apte, chief executive officer at Premier Biosoft.
To learn more about the technologies, please click on the links above.
